Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis

View source ↗

Summary

Clinical trial evaluating real-world effectiveness of benralizumab for allergic bronchopulmonary aspergillosis and severe asthma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benralizumab (benralizumab)

Snippet

Sponsor: Qianfoshan Hospital | Conditions: Allergic Bronchopulmonary Aspergillosis, Severe Asthma | Status: RECRUITING